Search

everythinglearnresearchcommunity

for

Search:↓

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Targeting Vδ1+T-cells may help treat alopecia areata.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

CD44 signaling can help heal wounds without scars.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

3D spheroid culture makes stem cells better at reducing inflammation.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Hair follicles help skin immune recovery after UVB exposure.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

CD201+ fascia progenitors are essential for wound healing and could be targeted for treating skin conditions.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Activating TLR3 boosts autophagy gene expression in skin cells.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.